[
biontech
]Latest from biontech
Qatar approves Pfizer/BioNTech vaccine for children aged 5-11 years
In November, Gulf states Bahrain and Saudi Arabia approved the Pfizer Covid-19 vaccine for emergency use for children in the same age category.
Published on Jan 30, 2022 09:21 PM IST
Reuters |
Omicron routs J&J vaccine in lab study, may evade Sinovac and BioNTech too
A study, conducted by scientists at the microbiology department of the University of Hong Kong, showed that insufficient antibodies were generated by the Sinovac and BioNTech products to fend off Omicron.
Published on Dec 15, 2021 01:26 PM IST
Written by Joydeep Bose | Edited by Avik Roy, Hindustan Times, New Delhi
Pfizer, BioNTech say 3 doses of Covid-19 vaccine neutralise Omicron variant
Further, the companies also said that two doses of the vaccine was found less effective in protection against the Omicron variant while a booster dose increased the neutralising antibodies by 25 times.
Published on Dec 08, 2021 07:47 PM IST
Written by Srivatsan K C | Edited by Avik Roy, Hindustan Times, New Delhi
Covid-19 vaccine makers study new variant’s impact
- BioNTech, which works with Pfizer said it’s beginning lab studies on the variant and should have the first data on how it interacts with the vaccine within two weeks.
Updated on Nov 28, 2021 04:21 AM IST
Agencies |
What are the Covid entry rules for travellers to European countries?
- As Europe begins to open up, DW offers a brief recap of what travel restrictions apply within the EU.
Updated on Aug 06, 2021 10:33 AM IST
Deutsche Welle, Delhi
